High Density Lipoprotein Particles (HDL-P): New Evidence & Emerging Application

This is a previously recorded webinar that was held live on October 10, 2012

This educational webinar reviews new data from the Multi-Ethnic Study of Atherosclerosis (MESA) and the Heart Protection Study (HPS) that compare HDL-C and HDL-P as independent measures of HDL-related risk.

Read more >

High-Density Lipoprotein Cholesterol and Particle Concentrations, Carotid Atherosclerosis, and Coronary Events

A recent study published in the Journal of American College of Cardiology (JACC) suggests that high density lipoprotein may be a more accurate indicator of cardiovascular risk than HDL-C. To view the article reprint, please click on the link or copy and paste into a new browser window.

http://digitalreprints.elsevier.com/i/75488

Read more >

HDL Particles: New Data and Clinical Perspectives

This presentation was delivered during the 2012 National Lipid Association Annual Scientific Sessions held in Phoenix, AZ June 1, 2012. This presentation will review the current controversies surrounding HDL-C and the data to support HDL-P and it’s associations with carotid atherosclerosis and incident CHD events. The program concludes with a clinical commentary from W. Virgil Brown, MD.

Read more >

Family medical history interactive e-Case

Expand your knowledge of family medical history as it relates to cardiovascular disease risk and patient management in an easy-to-use interactive case format. Get started on the interactive e-Case now.

See Case Study >

Diabetic Dyslipoproteinemia Interactive e-Case

Expand your knowledge of diabetic dyslipoproteinemia and personalized patient management in an easy-to-use interactive case format. Get started on the interactive e-Case now.

See Case Study >

Case study: A 52-year-old Male Patient with Family History of CVD

This case study follows the treatment of a 52-year-old male with a strong family history of early cardiovascular disease, and risk factors that include tobacco use, age (> 45 y/o) + early family history of CVD.

See Case Study >

CardioCare Live: Lipoprotein particle measurement in cardiovascular risk management and treatment

This video answers questions related to the relationship between low-density lipoprotein particle (LDL-P) elevation and residual cardiovascular risk in patients with “acceptable” levels of LDL cholesterol.

View event >

Webinar: Modern Lipid and Lipoprotein Measures

An informative session about the limitations of lipid measurements and the role of lipoproteins in the pathogenesis of atherosclerosis.

View event >

Lipoprotein Related Highlights from the National Lipid Association Annual Scientific Sessions

At the recent National Lipid Association Annual Scientific Sessions meeting in Scottsdale, AZ (May 31-June 2), four posters were presented that included lipoprotein particle analysis by NMR.

Read more >

0 Comments – 6/7/2012 3:13:58 PM

Heart Protection Study: Evidence for Personalized Management?

A paper examining lipid and lipoprotein particle associations with coronary events in the statin and placebo arms of the Heart Protection Study was published online in Circulation on April 26, 2012 (http://circ.

Read more >

0 Comments – 5/24/2012 12:48:50 PM

Contributing Editors

  • Merle Myerson, MD, EdD, FACC

    Director, Cardiovascular Disease
    Prevention Program
    St. Luke's & Roosevelt Hospitals, NYC

     


  • William Cromwell, MD, FAHA, FNLA

    Chief Medical Officer
    LipoScience, Inc.

  • Robert S. Rosenson, MD

    Professor, Department of Medicine/Cardiology Director, Cardiometabolic Disorders, Mount Sinai School of Medicine New York, NY

  • James A. Underberg, MD, FACPM, FACP, FNLA

    Preventative Cardiovascular Medicine
    Clinical Assistant Professor of Medicine
    New York University Medical School

  • Richard F. Wright, MD, FACC

    Vice Chair, American College of Cardiology Research Director and Director of the Heart Failure Center, Pacific Heart Institute Santa Monica, California